Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

Name: Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)
License: Public Domain

Hipra Scientific, S.L.U

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid-19, sars-cov-2 acute respiratory disease

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 226316
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.